S&P 500   4,273.79 (-0.20%)
DOW   33,562.86 (-0.59%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
S&P 500   4,273.79 (-0.20%)
DOW   33,562.86 (-0.59%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
S&P 500   4,273.79 (-0.20%)
DOW   33,562.86 (-0.59%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
S&P 500   4,273.79 (-0.20%)
DOW   33,562.86 (-0.59%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
LON:ALS

Altus Strategies (ALS) Share Forecast, Price & News

GBX 46
0.00 (0.00%)
(As of 08/15/2022)
Compare
Today's Range
44.44
48
50-Day Range
46
46
52-Week Range
40
82
Volume
20,768 shs
Average Volume
37,371 shs
Market Capitalization
£53.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ALS stock logo

About Altus Strategies (LON:ALS) Stock

Altus Strategies plc, together with its subsidiaries, acquires, discovers, explores for, and develops mineral properties in Africa. It primarily explores for gold, bauxite, copper, iron ore, zinc, nickel, lead, silver, tin, and tungsten deposits. The company has a portfolio of projects, including the Korali Sud (Diba) gold project and the Lakanfla gold project located in Western Mali; the Tabakorole gold project and the Pitiangoma Est gold project located in Southern Mali; the Wadi Jundi gold project, the Gabal Al-Shaluhl gold project, the Gabal Om Ourada gold project, the Wadi Dubur gold project located in Egypt; the Laboum gold project located in Northern Cameroon; the Bikoula iron ore project located in Southern Cameroon; the Izougza copper-silver project, the Azrar copper project, and the Tata copper project located in Western Morocco; the Daro copper-gold project and the Zager copper-gold project located in Northern Ethiopia; the Leopard Rock gold prospect located in Western Liberia; and the Toura nickel project located in Western Côte d'Ivoire. It also holds interest in various copper-silver projects in Morocco. The company was incorporated in 2007 and is based in Didcot, the United Kingdom.

Receive ALS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Altus Strategies and its competitors with MarketBeat's FREE daily newsletter.

ALS Stock News Headlines

Get MarketBeat All Access Free for 30 Days
MarketBeat All Access is the premier all-in-one stock research solution that helps you identify the best stocks, monitor your portfolio, and keep track of the market. You get our top stock picks, best-in-class research tools, real-time alerts, proprietary research reports and much more. Try it free for 30 days.
The Latest Analyst Ratings for Altus Power
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Altus Strategies: Scheme Becomes Effective
Altus Strategies PLC
Altus Strategies: Court Sanction of Scheme of Arrangement
See More Headlines

ALS Price History

Industry, Sector and Symbol

Industry
Industrial Metals & Minerals
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£661,496.00
Cash Flow
GBX 2.70 per share
Book Value
GBX 25.50 per share

Miscellaneous

Free Float
N/A
Market Cap
£53.97 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Steven James Poulton BSC (Age 45)
    MCSM, MSc, CEO & Exec. Director
    Comp: $242.5k
  • Mr. Martin John Keylock
    Chief Financial Officer
  • Mr. Alister Hume-Masterton (Age 33)
    Chief Investment Officer
    Comp: $141k
  • Mr. Matthew Roy Grainger B.Sc (Hons.) (Age 49)
    M.Sc, MCSM, Exec. Director
    Comp: $136k
  • Mr. William Slater
    VP of Operations
  • Ms. Sandra Naomi Bates (Age 49)
    Gen. Counsel
  • Mr. Michael Starke
    VP of Corp. Devel.
  • Ms. Amilha Pio Young (Age 59)
    Company Sec. & Legal Counsel
  • Ms. Val Mitchell
    Office & Fin. Mang.













ALS Stock - Frequently Asked Questions

How have ALS shares performed in 2023?

Altus Strategies' stock was trading at GBX 46 at the beginning of the year. Since then, ALS shares have increased by 0.0% and is now trading at GBX 46.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Altus Strategies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Altus Strategies investors own include NewAge (NBEV), Johnson Controls International (JCI), Hurricane Energy (HRCXF), EyeGate Pharmaceuticals (EYEG), Bank of America (BAC) and Adient (ADNT).

What is Altus Strategies' stock symbol?

Altus Strategies trades on the London Stock Exchange (LON) under the ticker symbol "ALS."

How do I buy shares of Altus Strategies?

Shares of ALS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Altus Strategies' stock price today?

One share of ALS stock can currently be purchased for approximately GBX 46.

How much money does Altus Strategies make?

Altus Strategies (LON:ALS) has a market capitalization of £53.97 million and generates £661,496.00 in revenue each year.

How can I contact Altus Strategies?

Altus Strategies' mailing address is 14 Station Road, The Orchard Centre, DIDCOT, OX11 7LL, United Kingdom. The official website for the company is www.altus-strategies.com. The company can be reached via phone at +44-1235-511767.

This page (LON:ALS) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -